Search results
Jun 5, 2024 · Our broad portfolio of approximately 280+ generic and specialty pharmaceuticals is the foundation from which we make healthy possible. And we expanded our portfolios to institutions, in biosimilars and across select international markets.
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets.
Together, we can do more to improve health. That’s a powerful reason to come to work. In addition to being guided by a deep sense of purpose, we’re also focused on rapidly growing our capabilities, our product portfolios and our people – all to increase the number of lives we can touch.
In the US, our portfolio of more than 280 medicines provides patients with more affordable access to quality medicines. Our growing Specialty portfolio meets important medical needs in neurology, endocrinology and other therapeutic categories.
Get the latest Amneal Pharmaceuticals Inc (AMRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
We deliver quality, trustand value. Our generics business is among the largest in the U.S. We develop, manufacture and commercialize complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals across a broad range of therapeutic categories.
